title: Photodynamic therapy for choroidal neovascularization in pediatric patients.
abstract: OBJECTIVE
  To report the use of photodynamic therapy (PDT) for choroidal neovascularization (CNV) in pediatric patients.
  
  
  METHODS
  Five patients (age range, 7-15 years) who underwent PDT for idiopathic CNV (n = 2) or CNV secondary to macular toxoplasmic scar (n = 3) were included in this study. Follow-up ranged from 12 months to 18 months. PDT was performed according to the standard protocol. We evaluated visual acuity, fluorescein leakage from the CNV, greatest linear dimension of the lesion, and occurrence of ocular or systemic adverse events at baseline and during follow-up.
  
  
  RESULTS
  No severe or moderate visual loss occurred in all cases during follow-up. PDT reduced CNV leakage in four cases. No serious ocular or systemic adverse events were recorded. Retinal pigment epithelium atrophic changes were observed around the regressed CNV, but they did not appear to cause visual loss.
  
  
  CONCLUSIONS
  PDT was safe for pediatric patients, and visual acuity was substantially stable after one or few treatments. Further follow-up is needed to assess if retinal pigment epithelium atrophic changes around the regressed CNV, possibly related to PDT, could affect vision in the long term.
authors.affiliation: Eye Clinic, Department of Oto-Neuro-Ophthalmological Surgical Sciences, University of Florence, Florence, Italy. fabriziogiansanti@interfree.it
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Giansanti
authors.forename: Gianni
authors.initials: G
authors.lastname: Virgili
authors.forename: Monica
authors.initials: M
authors.lastname: Varano
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Tedeschi
authors.forename: Emilio
authors.initials: E
authors.lastname: Rapizzi
authors.forename: Giovanni
authors.initials: G
authors.lastname: Giacomelli
authors.forename: Ugo
authors.initials: U
authors.lastname: Menchini
mesh_terms: D000293:Adolescent; D002648:Child; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D012449:Safety; D016896:Treatment Outcome; D000077362:Verteporfin; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin